Trading Report: Today, Israel Chemicals Ltd. (ICL) Announces Earnings Results

Today, Israel Chemicals Ltd. (ICL) Announces  Earnings Results

Israel Chemicals Ltd. (NYSE:ICL) announced its quarterly earnings data on Wednesday. The company reported $0.09 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.09. The firm earned $1.38 billion during the quarter. Israel Chemicals had a return on equity of 17.44% and a net margin of 7.40%. The firm’s revenue for the quarter was up .3% compared to the same quarter last year. During the same quarter last year, the company earned $0.12 EPS.

Shares of Israel Chemicals (NYSE:ICL) traded down 1.84% on Friday, reaching $3.73. The company’s stock had a trading volume of 6,579 shares. The company has a market capitalization of $4.75 billion, a price-to-earnings ratio of 11.77 and a beta of 1.14. Israel Chemicals has a 12-month low of $3.52 and a 12-month high of $5.23. The company’s 50-day moving average is $3.74 and its 200 day moving average is $3.99.

A number of large investors have recently added to or reduced their stakes in ICL. First Eagle Investment Management LLC increased its stake in Israel Chemicals by 0.3% in the second quarter. First Eagle Investment Management LLC now owns 29,583,977 shares of the company’s stock valued at $114,362,000 after buying an additional 97,067 shares during the period. Vanguard Group Inc. increased its stake in Israel Chemicals by 1.5% in the second quarter. Vanguard Group Inc. now owns 8,841,883 shares of the company’s stock valued at $34,484,000 after buying an additional 131,595 shares during the period. Migdal Insurance & Financial Holdings Ltd. bought a new stake in Israel Chemicals during the second quarter valued at approximately $11,135,000. Allianz Asset Management AG increased its stake in Israel Chemicals by 67.0% in the second quarter. Allianz Asset Management AG now owns 2,020,656 shares of the company’s stock valued at $7,829,000 after buying an additional 810,656 shares during the period. Finally, Foyston Gordon & Payne Inc increased its stake in Israel Chemicals by 0.8% in the second quarter. Foyston Gordon & Payne Inc now owns 2,008,715 shares of the company’s stock valued at $7,834,000 after buying an additional 16,631 shares during the period. 6.51% of the stock is currently owned by institutional investors and hedge funds.

Separately, Zacks Investment Research downgraded Israel Chemicals from a “buy” rating to a “hold” rating in a research note on Wednesday, November 2nd.

Related posts

Leave a Comment